![Vishwas Seshadri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vishwas Seshadri
Vorstandsvorsitzender bei
ABEONA THERAPEUTICS INC.
Vermögen: 8 Mio $ am 31.05.2026
Profil
Vishwas Seshadri is President, Chief Executive Officer & Director at Abeona Therapeutics, Inc. since 2021.
Formerly, Dr. Seshadri was Executive Director at Bristol Myers Squibb Co. from 2020 to 2021 and held the position of Head-Early Stage Upstream Process Development at Dr. Reddy's Laboratories, Inc. Dr. Seshadri earned a doctorate from the University of Arizona and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 1.374.079 ( 2,41 % ) | 8 Mio $ | 31.05.2026 |
Aktive Positionen von Vishwas Seshadri
| Unternehmen | Position | Beginn |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Vorstandsvorsitzender | 15.10.2021 |
Ehemalige bekannte Positionen von Vishwas Seshadri
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direktor/Vorstandsmitglied | 01.06.2021 |
Dr. Reddy's Laboratories, Inc.
 Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Corporate Officer/Principal | - |
Ausbildung von Vishwas Seshadri
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dr. Reddy's Laboratories, Inc.
Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Health Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
